The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.| U.S. Food and Drug Administration
From paper to pixels and maps to markets - a two-part series on India's geospatial renaissance and "the most important policy change since liberalisation"| tigerfeathers.substack.com